The Effect of Pre-Incision Field Block versus Post-Incision Inguinal Wound Infiltration on Postoperative Pain after Paediatric Herniotomy
DOI:
https://doi.org/10.3889/oamjms.2015.116Keywords:
Preincisional ilioinguinal/iliohypogastric nerve block, postincisional wound infiltration, pain score, HerniotomyAbstract
BACKGROUND: The Ilioinguinal/iliohypogastric nerve block has been shown to significantly decrease opioid analgesic requirements and side effects after inguinal herniotomy. We compared the effect of pre-incisional field block with 0.25% bupivacaine and post-incisional wound infiltration with 0.25% bupivacaine for postoperative pain control after inguinal herniotomy.
PATIENTS & METHODS: This was a randomized controlled double blind study in 62 ASA I and II children aged 1-7 years scheduled for inguinal herniotomy. They were assigned to receive either pre-incision field block (group I) or post-incision wound infiltration at the time of wound closure (group II). The pain score was assessed in the recovery room using mCHEOPS score and VAS or FLACC score at home by the parents for 24 hours.
RESULTS: The mean pain scores during the 2 hour stay in the recovery room, at 12 and 18 hours at home were similar in both groups, p > 0.05. However, the mean pain scores were significantly lower at 6 hours at home in group I (1.22 ± 0.57) than in group II (1.58 ±0.90), p <0.001, but significantly higher at 24 hours at home in group I (3.29 ± 0.46) than in group II (2.32 ± 0.24), p = 0.040.There was no difference in mean paracetamol requirement, and in the number of patients who required paracetamol for pain relief at home in both groups, p > 0.05.
CONCLUSION: We have demonstrated that both pre-incisional ilioinguinal/iliohypogastric field block and post incisional wound infiltration provided adequate postoperative analgesia for 24 hours after inguinal herniotomy.Downloads
Metrics
Plum Analytics Artifact Widget Block
References
Global Initiative for Asthma (GINA), GINA Report 2015, Global Strategy for Asthma Management and Prevention, updated 2015.
Barnes PJ. Theophylline. Am J Respir Crit Care Med. 2013;188(8):901-6.
http://dx.doi.org/10.1164/rccm.201302-0388PP DOI: https://doi.org/10.1164/rccm.201302-0388PP
PMid:23672674
Kawai M, Kato M. Theophylline for the treatment of bronchial asthma: Present status. Methods Find Exp Clin Pharmacol. 2000;22(5):309.
http://dx.doi.org/10.1358/mf.2000.22.5.796650 DOI: https://doi.org/10.1358/mf.2000.22.5.796650
PMid:11031732
Tilley SL. Handbook of Experimental Pharmacology. Methylxanthines in Asthma, 2011:pp 439-456.
http://dx.doi.org/10.1007/978-3-642-13443-2_17 DOI: https://doi.org/10.1007/978-3-642-13443-2_17
MorfÃn Maciel BM, Castillo MorfÃn BM. Theophylline, a new look to an old drug. Rev Alerg Mex. 2010;57(4):112-22.
PMid:21255523
Ito K, Lim S, Caramori G, Cosio B, Chung KF, Adcock IM, Barnes PJ. A molecular mechanism of action of theophylline: Induction of histone deacetylase activity to decrease inflammatory gene expression. Proc Natl Acad Sci USA. 2002;99(13):8921-6.
http://dx.doi.org/10.1073/pnas.132556899 DOI: https://doi.org/10.1073/pnas.132556899
PMid:12070353 PMCid:PMC124399
Zevin S, Benowitz NL. Drug interactions with tobacco smoking. An update. Clin Pharmacokinet. 1999;36(6):425-38.
http://dx.doi.org/10.2165/00003088-199936060-00004 DOI: https://doi.org/10.2165/00003088-199936060-00004
PMid:10427467
Thomson NC, Chaudhuri R, Livingston E. Asthma and cigarette smoking. European Respiratory Journal. 2004;24:822–833.
http://dx.doi.org/10.1183/09031936.04.00039004 DOI: https://doi.org/10.1183/09031936.04.00039004
PMid:15516679
Muir KT, Jonkman JH, Tang DS, Kunitani M, Riegelman S. Simultaneous determination of theophylline and its major metabolites in urine by reversed-phase ion-pair high-performance liquid chromatography. Journal of Chromatography B: Biomedical Sciences and Applications. 1980;221(1): 85-95.
http://dx.doi.org/10.1016/S0378-4347(00)81010-5 DOI: https://doi.org/10.1016/S0378-4347(00)81010-5
Thomson NC. Smokers with asthma: what are the management options? Am J Respir Crit Care Med. 2007;175(8):749-50.
http://dx.doi.org/10.1164/rccm.200701-017ED DOI: https://doi.org/10.1164/rccm.200701-017ED
PMid:17484086
Chalmers GW, et al. Smoking and airway inflammation in patients with mild asthma. Chest. 2001;120(6):1917-22.
http://dx.doi.org/10.1378/chest.120.6.1917 DOI: https://doi.org/10.1378/chest.120.6.1917
PMid:11742922
Hylkema NM, Sterk PJ, De Boer WI, Postma DS. Tobacco use in relation to COPD and asthma. Eur Resp J. 2007: 29(3):438-445.
http://dx.doi.org/10.1183/09031936.00124506 DOI: https://doi.org/10.1183/09031936.00124506
PMid:17329490
Kroon LA. Drug interactions with smoking. Am J Health-Syst Pharm. 2007;64:1917-1921.
http://dx.doi.org/10.2146/ajhp060414 DOI: https://doi.org/10.2146/ajhp060414
PMid:17823102
Thomson NC, Spears M. The influence of smoking on the treatment response in patients with asthma. Curr Opin Allergy Clin Immunol. 2005;5(1):57-63.
http://dx.doi.org/10.1097/00130832-200502000-00011 DOI: https://doi.org/10.1097/00130832-200502000-00011
Spears M, et al. Effect of low-dose theophylline plus beclometasone on lung function in smokers with asthma: a pilot study. Eur Resp J. 2009;33(5):1010-1017.
http://dx.doi.org/10.1183/09031936.00158208 DOI: https://doi.org/10.1183/09031936.00158208
PMid:19196814
Stapleton M, Howard-Thompson A, George Ch, Hoover MR, Self HT. Smoking and Asthma. J Am Board Fam Med. 2011;24:313-322.
http://dx.doi.org/10.3122/jabfm.2011.03.100180 DOI: https://doi.org/10.3122/jabfm.2011.03.100180
PMid:21551404
An-Soo Jang, at al. The Impact of Smoking on Clinical and Therapeutic Effects in Asthmatics. J Korean Med Sci. 2009;24(2):209-214.
http://dx.doi.org/10.3346/jkms.2009.24.2.209 DOI: https://doi.org/10.3346/jkms.2009.24.2.209
PMid:19399260 PMCid:PMC2672118
Downloads
Published
How to Cite
Issue
Section
License
http://creativecommons.org/licenses/by-nc/4.0